Chongqing Taiji Industry's announcement regarding the retirement and departure of the director.
Announcement of the resolution of the 21st meeting of the 10th board of directors of Chongqing Taiji Industry.
Announcement of Chongqing Taiji Industry on returning the idle raised funds to supplement working capital.
Announcement from Chongqing Taiji Industry regarding the Consistency Evaluation of Generic Drugs of Penicillin V Potassium Tablets
Taiji Group's announcement on the company's main operating data for the first quarter of 2024
Taiji Group's announcement on holding a performance briefing for the first quarter of 2024
Taiji Group Announcement on Fluorouracil Injection Passing Generic Drug Consistency Evaluation
Taiji Group's Announcement on Providing Guarantee Amounts for Holding Subsidiaries
Taiji Group Special Audit Instructions on Non-operating Capital Occupation and Other Related Fund Transactions-Tianjianshen [2024] No. 1-198
Announcement of Resolutions of the 19th Meeting of the 10th Board of Directors of Taiji Group
Taiji Group 2023 Accounting Firm Performance Assessment Report
Taiji Group's Report on Continued Risk Assessment of Sinopharm Group Finance Co., Ltd.
Special opinion of the board of directors of Taiji Group on the 2023 independent directors' independence self-inspection
Taiji Group Foreign Donations Management Measures (2024 Revision)
Taiji Group 2023 Independent Director Debriefing Report-Xiong Shaoxi
Taiji Group 2023 Independent Director Debriefing Report-He Hongtao
Taiji Group 2023 Independent Director Debriefing Report-Shen Ling
Taiji Group 2023 Independent Director Debriefing Report-Wu Xian
Taiji Group 2023 Independent Director Debriefing Report-Tian Weixing
Announcement of Resolutions of the 16th Meeting of the 10th Board of Supervisors of Taiji Group
No Data